Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

POLYMYXIN B for Dermatomyositis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where POLYMYXIN B was used for Dermatomyositis.

Most Reported Side Effects for POLYMYXIN B

Side Effect Reports % Deaths Hosp.
Drug ineffective 260 40.4% 36 81
Macular degeneration 168 26.1% 0 44
Off label use 85 13.2% 11 53
Pain 66 10.3% 0 37
Drug hypersensitivity 62 9.6% 0 2
Nausea 62 9.6% 1 41
Acute kidney injury 53 8.2% 7 21
Pyrexia 43 6.7% 2 42
Malaise 42 6.5% 1 38
Paraesthesia oral 42 6.5% 0 39
Infusion related reaction 40 6.2% 1 38
Weight decreased 40 6.2% 0 40
Therapeutic product effect incomplete 39 6.1% 0 39
Chronic sinusitis 38 5.9% 0 38
Dyspepsia 38 5.9% 0 38

Other Indications for POLYMYXIN B

Product used for unknown indication (211) Pneumonia (46) Acinetobacter infection (39) Klebsiella infection (28) Pseudomonas infection (26) Anti-infective therapy (19) Antibiotic therapy (17) Cystic fibrosis (17) Sepsis (14) Bacterial infection (10)

Other Drugs Used for Dermatomyositis

RITUXIMAB (993) METHOTREXATE (958) HUMAN IMMUNOGLOBULIN G (913) PREDNISONE (744) PREDNISOLONE (652) METHYLPREDNISOLONE (647) MYCOPHENOLATE MOFETIL (636) TACROLIMUS (626) CYCLOPHOSPHAMIDE (511) HYDROXYCHLOROQUINE (419)

Related Pages

POLYMYXIN B Full Profile All Dermatomyositis Drugs POLYMYXIN B Demographics POLYMYXIN B Timeline